Expert Interview
Examining the current use of Dapagliflozin (Farxiga) in the heart failure treatment landscape
Ticker(s): AZN, LLYInstitution: Cardiovascular associates of the Delaware Valley
- Cardiologist at Cardiovascular associates of the Delaware Valley
- Manages roughly 60 patients monthly with heart failure
- Currently prescribes farxiga to 20 - 30 percent of patients with CHF
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
